The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
October 4th 2024
A review of 5 highly anticipated FDA decisions expected by year-end, including acoramidis for ATTR-CM, olezarsen for FCS, sotagliflozin for T1D and CKD, and more.
September 18th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Empagliflozin Reduces Liver Fat in Early Diabetes
February 19th 2020Researchers writing in Diabetes Care this month report that empagliflozin, a sodium–glucose cotransporter 2 inhibitor (SGLT2), successfully reduced liver fat content in recent-onset and metabolically well-controlled type 2 diabetes (T2D).
Probiotics Protect Against Lumbar Spine Bone Loss in Early Menopause
January 28th 2020Probiotic supplementation using a mix of three Lactobacillus strains naturally occurring in the human gut microbiota protects against lumbar spine bone loss in healthy, early postmenopausal women, say researchers recently writing in The Lancet Rheumatology.
Image IQ: Depression, Tingling and Numbness
January 8th 2020A 38-year-old woman went to the doctor with several complaints that seemed unrelated but they had started within the last few months. She was feeling depressed and fatigued with tingling and numbness in her hands and feet. Can you diagnose this patient?